Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

103.45
+0.06000.06%
Pre-market: 103.39-0.0600-0.06%07:19 EST
Volume:2.37M
Turnover:245.38M
Market Cap:19.74B
PE:-93.87
High:103.67
Open:103.60
Low:103.38
Close:103.39
52wk High:103.67
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:1.16
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1021
EPS(LYR):-1.1021
ROE:-8.66%
ROA:-1.59%
PB:8.22
PE(LYR):-93.87

Loading ...

Exact Sciences: Strong Q3 Performance and Promising Outlook Drive Buy Rating and Increased Price Target

TIPRANKS
·
Nov 04, 2025

Exact Sciences Reports Record Q3 Revenue and Raises Guidance

TIPRANKS
·
Nov 04, 2025

Stock Track | Exact Sciences Soars 7.69% After Hours on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 04, 2025

Stock Track | Exact Sciences Soars 7.69% as Q3 Earnings Beat Expectations and 2025 Guidance Raised

Stock Track
·
Nov 04, 2025

Exact Sciences Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 04, 2025

Exact Sciences Q3 Adjusted Net Income, Revenue Rise; Shares Gain After Hours

MT Newswires Live
·
Nov 04, 2025

Cancer screening firm Exact Sciences beats Q3 revenue estimates, raises 2025 revenue forecast

Reuters
·
Nov 04, 2025

Stock Track | Exact Sciences Soars 6.38% After Hours on Q3 Earnings Beat, Strong Revenue Growth

Stock Track
·
Nov 04, 2025

GUIDANCE: (EXAS) Exact Sciences Expects Full Year 2025 Revenue Range $3.22B - $3.24B, vs. FactSet Est of $3.16B

MT Newswires Live
·
Nov 04, 2025

Exact Sciences reports $851 million revenue for Q3 2025

Reuters
·
Nov 04, 2025

BRIEF-Exact Sciences Q3 Basic EPS USD -0.1

Reuters
·
Nov 04, 2025

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?

Benzinga_recent_news
·
Nov 04, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 03, 2025

William Blair Reaffirms Their Buy Rating on Exact Sciences (EXAS)

TIPRANKS
·
Oct 29, 2025

Piper Sandler Sticks to Its Buy Rating for Exact Sciences (EXAS)

TIPRANKS
·
Oct 28, 2025

EXACT Sciences Director Katherine S. Zanotti Reports Sale of Common Shares

Reuters
·
Oct 28, 2025

Exact Sciences’ Latest Study on Breast Cancer Recurrence Detection: A Potential Game Changer

TIPRANKS
·
Oct 28, 2025

Exact Sciences Is Maintained at Buy by BTIG

Dow Jones
·
Oct 22, 2025

EXAS, GH, PLTR, SOFI: Cathie Wood Invests $5.5M in Exact Sciences, Trims Stakes in Guardant, Palantir, SoFi, and Other Big Names

TIPRANKS
·
Oct 21, 2025

Leerink Partners Reaffirms Their Buy Rating on Exact Sciences (EXAS)

TIPRANKS
·
Oct 17, 2025